Early Access Program (EAP) For The Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) With Pegcetacoplan
Latest Information Update: 29 Jul 2024
At a glance
- Drugs Pegcetacoplan (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Expanded access; Therapeutic Use
- 02 Jun 2021 Status changed from recruiting to completed.
- 29 Nov 2020 New trial record